Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1)

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 530-538

  Loe, Douglas W ^a   Deeley, Roger G ^a   Cole, Susan P C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG UPTAKE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSPORT KINETICS;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; GLUTATHIONE; HELA CELLS; HUMANS; KINETICS; LEUKOTRIENE C4; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; STIMULATION, CHEMICAL; VERAPAMIL;

EID: 0034012019     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Barrand MA, Rhodes T, Center MS and Twentyman PR (1993) Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer 29:408-415.
2. Binaschi M, Supino R, Gambetta RA, Giaccone G, Prosperi E, Capranico G, Cataldo I and Zunino F (1995) MRP gene overexpression is a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance, Int J Cancer 62:84-89.
3. Chan HSL, Lu Y, Grogan TM, Haddad G, Hipfner DR, Cole SPC, Deeley RG, Ling V and Gallie BL (1997) Multidrug resistance protein (MRP) expression in retinoblastoma correlates with rare failure of chemotherapy despite cyclosporine for reversal of P-glycoprotein. Cancer Res 57:2325-2330.
4. Cole SPC (1992) The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer. Can J Physiol Pharmacol 70:313-329.
5. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash DC) 258:1650-1654.
6. Cole SPC, Downes HF and Slovak ML (1989) Effect of calcium antagonists on the chemosensitivity of two multidrug resistant human tumour cell lines which do not overexpress P-glycoprotein. Br J Cancer 59:42-46.
7. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910.
8. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP and Salmon SE (1989) Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415-424.
9. Davey RA, Longhurst TJ, Davey MW, Belov L, Harvie RM, Hancox D and Wheeler H (1995) Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leuk Res 19:275-282.
10. De Jong S. Zijlstra JG, De Vries EGE and Mulder NH (1990) Reduced DNA topo-isomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 50:304-309.
11. Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP and Gutheil JC (1995) An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer 72:535-542.
12. Evers R, Zaman GJR, Van Deemster L, Jansen H, Calafat J, Oomen LCJM, Oude Elferink RPJ, Borst P and Schinkel AH (1996) Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J Clin Invest 97:1211-1218.
13. Eytan GD, Regev R, Oren G and Assaraf YG (1996) The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem 271: 12897-12902.
14. Gottesman MM and Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427.
15. Grech KV, Davey RA and Davey MW (1998) The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells. Biochem Pharmacol 55:1283-1289.
16. Hipfner DR, Deeley RG and Cole SPC (1999a) Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1461:359-376.
17. Hipfner DR, Mao Q, Qiu W, Leslie EM, Deeley RG and Cole SPC (1999b) Monoclonal antibodies that inhibit the transport function of the 190 kDa multidrug resistance protein, MRP: Localization of their epitopes to the nucleotide binding domains of the protein. J Biol Chem 274:15420-15426.
18. Karwinski W, Garcia R and Helton WS (1996) Protective effects of the calcium channel blocker verapamil on hepatic function following warm ischemia. J Surg Res 64:150-155.
19. Keppler D, Leier I and Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791.
20. Konig J, Rost D, Cui Y and Keppler D (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156-1163.
21. Lautier D, Canitrot Y, Deeley RG and Cole SPC (1996) Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol 52:967-977.
22. Leier I, Jedlitschky G, Buchholz U, Center M, Cole SPC, Deeley RG and Keppler D (1996) ATP-dependent glutathione disulfide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 314:433-437.
23. Li Z, Szczypka MS, Lu Y, Thiele DJ and Rea PA (1996) The yeast cadmium factor protein (YCF1) is a vacuolar glutathione S-conjugate pump. J Biol Chem 271: 6509-6517.
24. 4 and chemotherapeutic agents in membrane vesicles: Demonstration of glutathione-dependent vincristine transport. J Biol Chem 271:9675-9682.
25. Loe DW, Deeley RG and Cole SPC (1998) Characterization of vincristine transport by the 190 kDa multidrug resistance protein, MRP: Evidence for co-transport with reduced glutathione. Cancer Res 58:5130-5136.
26. 1 and its glutathione conjugates by the product of the MRP gene. Mol Pharmacol 51:1034-1041.
27. Lu SC, Cai J, Kuhlenkamp J, Sun W-M, Takakawa H, Takenaka O, Horie T, Yi J and Kaplowitz N (1996) Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats. Hepatology 24:253-258.
28. McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL and Center MS (1989) Mechanisms of multidrug resistance in HL60 cells: Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 38:3611-3619.
29. Paulusma CC, Van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P and Oude Elferink RPJ (1999) Canalicular multispecific organic anion transporter/ multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 338:393-401.
30. Rappa G, Finch RA, Sartorelli AC and Lorico A (1999) New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. Biochem Pharmacol 58:557-562.
31. Rebbeor JF, Connolly GC, Dumont ME and Ballatori N (1998) ATP-dependent transport of reduced glutathione on YCF1, the yeast orthologue of mammalian multidrug resistance associated proteins. J Biol Chem 273:33449-33454.
32. Renes J, De Vries EGE, Nienhuis EF, Jansen PLM and Muller M (1999) ATP-and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol 126:681-688.
33. Shapiro AB and Ling V (1995) Using purified P-glycoprotein to understand multidrug resistance. J Bioenerg Biomembr 27:7-13.
34. Sharom FJ (1997) The P-glycoprotein efflux pump: How does it transport drugs? J Membr Biol 160:161-175.
35. Stewart AJ, Canitrot Y, Baracchini E, Dean NM, Deeley RG and Cole SPC (1996) Reduction in the expression of the multidrug resistance protein, MRP, in human tumour cells by antisense phosphorothioate oligonucleotides. Biochem Pharmacol 51:461-469.
36. 2+ channels. Proc Natl Acad Sci USA 87:9108-9112.
37. Suzuki H and Sugiyama Y (1998) Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2. Semin Liver Dis 18:359-376.
38. Taguchi Y. Yoshida A, Takada Y, Komano T and Ueda K (1997) Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett 401:11-14.
39. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972.
40. Versantvoort CHM, Bagruj T, Wright KA and Twentyman PR (1995) On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer 63:855-862.
41. Yin M, Bankusli I and Rustum YM (1989) Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice. Cancer Res 49:4729-4733.
42. Zaman GJR, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RPJ, Baas F and Borst P (1995) Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690-7694.